Yong-feng Yang

1-1 Zhongfu Road
Nanjing, 210003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Letter: Validation of the international multisociety diagnostic scoring system for PSVD/NCPF in a Chinese cohort.

Letter: Validation of the international multisociety diagnostic scoring system for PSVD/NCPF in a Chinese cohort.

Journal: Journal of hepatology

Published: July 10, 2026

DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?

DR1-DR2 enrichment in HBeAg-negative chronic hepatitis B: integration hotspot or survivor signature?

Journal: Gut

Published: July 01, 2026

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Reply.

Letter: Incremental Value and Stratified Interpretation of Dual Autoantibody Positivity in Primary Biliary Cholangitis. Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 05, 2026

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' Reply.

Letter: Double PBC-Related Autoantibody Positivity-How Essential Is It for Diagnosis? Authors' Reply.

Journal: Alimentary pharmacology & therapeutics

Published: April 05, 2026

Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitis.

Letter: The association between liver biochemistry, biliary and fibrosis in primary biliary cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: February 01, 2026

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

Characteristics and Outcomes of Patients With Imaging-Defined MASLD and Histological Steatosis Grade S0.

Journal: The American journal of gastroenterology

Published: January 19, 2026

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.

Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0.

Journal: The American journal of gastroenterology

Published: January 19, 2026

Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase.

Histopathological Features and Antiviral Efficacy in Patients Over 30 Years Old with Chronic Hepatitis B in the Indeterminate Phase.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: December 17, 2025

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Dual Positivity for AMA/AMA-M2 and Anti-gp210/sp100 Shows Highest Diagnostic Value for Primary Biliary Cholangitis.

Journal: Alimentary pharmacology & therapeutics

Published: November 20, 2025

Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes.

Extrahepatic Autoimmune Diseases in Autoimmune Hepatitis: Their Prevalence, Predictors, and Influence on Early Treatment Outcomes.

Journal: Journal of clinical and translational hepatology

Published: August 19, 2025

A novel Halo Tag-based photo-crosslinking system for efficient drug target identification via chemoproteomic profiling.

A novel Halo Tag-based photo-crosslinking system for efficient drug target identification via chemoproteomic profiling.

Journal: Analytica chimica acta

Published: July 04, 2025

Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study.

Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter study.

Journal: Med (New York, N.Y.)

Published: June 21, 2025

Showing 1-12 of 48

Last Updated: 09/26/2026